Trial Profile
Solifenacin vs Levofloxacin vs Lornoxicam for Management of Intravesical Instillation of Bacillus Calmette-Guerin (BCG) Side Effects A Single Blinded Randomised Controlled Study
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Levofloxacin (Primary) ; Lornoxicam (Primary) ; Solifenacin (Primary)
- Indications Bladder cancer
- Focus Therapeutic Use
- 19 May 2017 Status changed from recruiting to active, no longer recruiting.
- 03 Feb 2017 New trial record